Vimarsana
Biggest News Aggregation in the World

Page 3 - Human Genetics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Human Genetics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Human Genetics Today - Breaking & Trending Today

Prof. Jay Shendure Joins Somite Therapeutics as Scientific Co-founder - Vimarsana News

Prof. Jay Shendure Joins Somite Therapeutics as Scientific Co-founder

/PRNewswire/ -- Somite Therapeutics, a tech-bio company harnessing big data and AI to pioneer novel cell replacement therapies, is thrilled to announce the...

Why patient-centricity is key for rare disease clinical research - Vimarsana News

Why patient-centricity is key for rare disease clinical research

Adopting patient-centric approaches to help overcome the unique challenges related to clinical trials for rare diseases.

Aliens in our seas | Ahmedabad News - Times of India - Vimarsana News

Aliens in our seas | Ahmedabad News - Times of India

Gujarat's 1,600km coastline, including port cities, faces a threat from alien aquatic species introduced through ship ballast water discharge, impacti

Capsida Biotherapeutics Presents New Preclinical Evidence Indicating Novel First-in-Class IV-Administered Gene Therapy Effectively Treats Genetic Epilepsy Due to STXBP1 Mutations - Vimarsana News

Capsida Biotherapeutics Presents New Preclinical Evidence Indicating Novel First-in-Class IV-Administered Gene Therapy Effectively Treats Genetic Epilepsy Due to STXBP1 Mutations

/PRNewswire/ -- Capsida Biotherapeutics ("Capsida") today announced new preclinical data supporting the potential of Capsida's gene therapy candidate, CAP-002,...

Genomics plc and GSK collaborate to harness polygenic risk scores in clinical trials - Vimarsana News

Genomics plc and GSK collaborate to harness polygenic risk scores in clinical trials

Genomics plc and GSK announced a new collaboration to explore the potential for using polygenic risk scores (PRS) in clinical trials, to improve understanding of disease risk and patient selection, which could support optimization of trial design.